M. J. Najafzadeh Et Al. , "COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance," Medical Mycology , vol.62, no.4, 2024
Najafzadeh, M. J. Et Al. 2024. COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance. Medical Mycology , vol.62, no.4 .
Najafzadeh, M. J., Shaban, T., Zarrinfar, H., Sedaghat, A., Hosseinikargar, N., Berenji, F., ... Jalali, M.(2024). COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance. Medical Mycology , vol.62, no.4.
Najafzadeh, Mohammad Et Al. "COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance," Medical Mycology , vol.62, no.4, 2024
Najafzadeh, Mohammad J. Et Al. "COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance." Medical Mycology , vol.62, no.4, 2024
Najafzadeh, M. J. Et Al. (2024) . "COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance." Medical Mycology , vol.62, no.4.
@article{article, author={Mohammad Javad Najafzadeh Et Al. }, title={COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance}, journal={Medical Mycology}, year=2024}